Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - LONG-TERM INVESTMENTS
Long-term Investments NBIX - Neurocrine Biosciences, Inc.
125 M
LAST VALUE
-44.25%
2 YEAR CAGR
-18.89%
5 YEAR CAGR
12.78%
10 YEAR CAGR